Goodwin Procter represented Intellia Therapeutics, while Latham & Watkins LLP represented the underwriter in the offering.Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now